Laboratorio de Oncología Molecular y TGFβ, Instituto Murciano de Investigaciones Biosanitarias Arrixaca, El Palmar, Murcia, Spain.
Servicio de Oncología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain.
Cell Commun Signal. 2017 Nov 29;15(1):50. doi: 10.1186/s12964-017-0205-y.
The simplicity of Transforming Growth Factor ß (TGFβ) signaling pathway, linear and non-amplified, hardly sustains its variety of responses. This is often justified by the complex regulation showed by Smad proteins, TGFβ signaling intracellular transducers, object of post-translational modifications that modulate TGFβ-dependent transcription. Protein acetylation is emerging as a compelling mechanism affecting the activities of significant transcription factors, including p53, FOXO or NF-kB. Smad proteins might be controlled by this mechanism, implying that accessory factors capable of altering Smads-transcriptional complexes acetylation status and hence regulate TGFβ responses remain to be identified. Understanding this interaction may help in the assessment of TGFβ signaling outcomes, extending from healthy physiology to pathological conditions and cancer.
A two-hybrid chimera interacting system allowed to identify Sirt1, a NAD+ dependent type III histone deacetylase, as a novel Smad2 interactor. Several well stablished cellular models were applied to characterize this interaction by means of co-immunoprecipitation of tagged proteins and immuno-fluorescence staining. The occurrence of the interaction at Smad2 driven transcriptomic complexes was studied by means of DNA-pull-down and chromatin immunoprecipitation (ChIP), while its effects were assessed by protein over-expression and siRNA applied into a TGFβ-dependent reporter gene assay.
The interaction was confirmed and observed to be enhanced upon Smad2 acetylation, a known feature of active and nuclear Smad2. However, Sirt1 did not play a major role in Smad2 deacetylation. Anti-Sirt1 ChIP showed increased recovery of promoter regions corresponding to Smad2-driven genes after TGFβ-stimulation, while its occurrence at Smad2-dependent transcriptomic complexes on DNA was found to effectively modulate gene expression.
Sirt1 presence on Smad2-driven TGFβ-dependent regulatory elements was detected and found to increase after TGFβ treatment. Moreover, Sirt1 overexpression resulted in a decrease of the activity of a Smad2-driven TGFβ-dependent reporter gene, while Sirt1 interference increased its activity. This would confirm the relevance of the discovered Sirt1-Smad2 interaction for the regulation of TGFβ-dependent gene transcription.
转化生长因子 β(TGFβ)信号通路简单、线性且非放大,难以维持其多种反应。这通常可以通过 Smad 蛋白的复杂调节来解释,Smad 蛋白是 TGFβ 信号转导的细胞内转导子,是调节 TGFβ 依赖性转录的翻译后修饰的对象。蛋白质乙酰化作为一种影响重要转录因子(包括 p53、FOXO 或 NF-kB)活性的有说服力的机制正在出现。Smad 蛋白可能受到这种机制的控制,这意味着能够改变 Smad-转录复合物乙酰化状态并因此调节 TGFβ 反应的辅助因子仍有待确定。了解这种相互作用可能有助于评估 TGFβ 信号转导的结果,从健康生理学扩展到病理条件和癌症。
双杂交嵌合体相互作用系统鉴定出 Sirt1(一种 NAD+ 依赖性 III 型组蛋白去乙酰化酶)是 Smad2 的新型相互作用蛋白。通过标记蛋白的共免疫沉淀和免疫荧光染色,应用几种成熟的细胞模型来表征这种相互作用。通过 DNA 下拉和染色质免疫沉淀(ChIP)研究了该相互作用在 Smad2 驱动的转录复合物中的发生情况,同时通过蛋白过表达和 TGFβ 依赖性报告基因测定中的 siRNA 应用评估了其作用。
证实了该相互作用,并观察到在 Smad2 乙酰化时增强,这是活性和核 Smad2 的已知特征。然而,Sirt1 在 Smad2 去乙酰化中并没有起主要作用。抗 Sirt1 ChIP 显示,在 TGFβ 刺激后,Smad2 驱动基因的启动子区域的恢复增加,而在 DNA 上的 Smad2 依赖性转录复合物中的存在被发现可有效调节基因表达。
检测到 Sirt1 存在于 Smad2 驱动的 TGFβ 依赖性调节元件中,并在 TGFβ 处理后发现增加。此外,Sirt1 的过表达导致 Smad2 驱动的 TGFβ 依赖性报告基因活性降低,而 Sirt1 干扰则增加其活性。这将证实所发现的 Sirt1-Smad2 相互作用对于调节 TGFβ 依赖性基因转录的相关性。